U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT06893575) titled 'WhatsApp-Based Sleep Intervention in Heart Failure Patients' on March 18.
Brief Summary: Heart failure (HF) is a growing global health issue, with increasing prevalence among aging populations. In Turkey, the prevalence of HF was 2.114% in 2022, affecting approximately three million individuals. HF patients often experience poor sleep quality due to symptoms like dyspnea, fatigue, and fluid retention, which significantly impact their overall health and quality of life. Sleep disorders, particularly obstructive and central sleep apnea, are commonly reported among HF patients, exacerbating disease progression and increasing morbidity...